MicroRNA-target cross-talks: Key players in glioblastoma multiforme.

作者: Eman Ali Toraih , Nagwa Mahmoud Aly , Hoda Y Abdallah , Saeed Awad Al-Qahtani , Aly AM Shaalan

DOI: 10.1177/1010428317726842

关键词: GlioblastomaMethylationCancer researchPolymerase chain reactionMedicineAggressive diseasemicroRNAImmunohistochemistryOncogeneSuppressor

摘要: The role of microRNAs in brain cancer is still naive. Some act as oncogene and others tumor suppressors. Discovery efficient biomarkers mandatory to debate that aggressive disease. Bioinfo...

参考文章(171)
S.-D. Hsu, C.-H. Chu, A.-P. Tsou, S.-J. Chen, H.-C. Chen, P. W.-C. Hsu, Y.-H. Wong, Y.-H. Chen, G.-H. Chen, H.-D. Huang, miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes Nucleic Acids Research. ,vol. 36, pp. 165- 169 ,(2007) , 10.1093/NAR/GKM1012
You, Analysis of miR-221 and p27 expression in human gliomas Molecular Medicine Reports. ,vol. 2, pp. 651- 656 ,(2009) , 10.3892/MMR_00000152
Peter Pytel, M. Kelly Nicholas, Rimas V. Lukas, Steven Chmura, Bakhtihar Yamini, Maciej Lesniak, Molecular Heterogeneity in Glioblastoma: Therapeutic Opportunities and Challenges Seminars in Oncology. ,vol. 38, pp. 243- 253 ,(2011) , 10.1053/J.SEMINONCOL.2011.01.009
Bryan T. MacDonald, Keiko Tamai, Xi He, Wnt/β-catenin signaling: components, mechanisms, and diseases Developmental Cell. ,vol. 17, pp. 9- 26 ,(2009) , 10.1016/J.DEVCEL.2009.06.016
Sith Sathornsumetee, Annick Desjardins, James J. Vredenburgh, Roger E. McLendon, Jennifer Marcello, James E. Herndon, Alyssa Mathe, Marta Hamilton, Jeremy N. Rich, Julie A. Norfleet, Sridharan Gururangan, Henry S. Friedman, David A. Reardon, Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma Neuro-oncology. ,vol. 12, pp. 1300- 1310 ,(2010) , 10.1093/NEUONC/NOQ099
Yang Li, Chengxiang Qiu, Jian Tu, Bin Geng, Jichun Yang, Tianzi Jiang, Qinghua Cui, HMDD v2.0: a database for experimentally supported human microRNA and disease associations Nucleic Acids Research. ,vol. 42, pp. 1070- 1074 ,(2014) , 10.1093/NAR/GKT1023
Jennifer S Carew, Peng Huang, Mitochondrial defects in cancer Molecular Cancer. ,vol. 1, pp. 9- 9 ,(2002) , 10.1186/1476-4598-1-9
J. T. Huse, C. Brennan, D. Hambardzumyan, B. Wee, J. Pena, S. H. Rouhanifard, C. Sohn-Lee, C. le Sage, R. Agami, T. Tuschl, E. C. Holland, The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo Genes & Development. ,vol. 23, pp. 1327- 1337 ,(2009) , 10.1101/GAD.1777409
Frederic M. Waldman, Carlos Cordon-Cardo, Adam B. Olshen, Adam B. Olshen, Jane Fridlyand, James E. Korkola, Joris A. Veltman, Donna Albertson, Ajay N. Jain, Peter Carroll, Daniel Pinkel, Sandy DeVries, Sunanda Pejavar, Wen Lin Kuo, Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Research. ,vol. 63, pp. 2872- 2880 ,(2003)
Roel GW Verhaak, Katherine A Hoadley, Elizabeth Purdom, Victoria Wang, Yuan Qi, Matthew D Wilkerson, C Ryan Miller, Li Ding, Todd Golub, Jill P Mesirov, Gabriele Alexe, Michael Lawrence, Michael O'Kelly, Pablo Tamayo, Barbara A Weir, Stacey Gabriel, Wendy Winckler, Supriya Gupta, Lakshmi Jakkula, Heidi S Feiler, J Graeme Hodgson, C David James, Jann N Sarkaria, Cameron Brennan, Ari Kahn, Paul T Spellman, Richard K Wilson, Terence P Speed, Joe W Gray, Matthew Meyerson, Gad Getz, Charles M Perou, D Neil Hayes, None, Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1 Cancer Cell. ,vol. 17, pp. 98- 110 ,(2010) , 10.1016/J.CCR.2009.12.020